Sfoglia per Autore
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients
2024 Villa, M; Malighetti, F; Sala, E; Sharma, G; Arosio, G; Gemelli, M; Manfroni, C; Fontana, D; Cordani, N; Meneveri, R; Zambon, A; Piazza, R; Pagni, F; Cortinovis, D; Mologni, L
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis
2024 Crespiatico, I; Zaghi, M; Mastini, C; D'Aliberti, D; Mauri, M; Mercado, C; Fontana, D; Spinelli, S; Crippa, V; Inzoli, E; Manghisi, B; Civettini, I; Ramazzotti, D; Sangiorgio, V; Gengotti, M; Brambilla, V; Aroldi, A; Banfi, F; Barone, C; Orsenigo, R; Riera, L; Riminucci, M; Corsi, A; Breccia, M; Morotti, A; Cilloni, D; Roccaro, A; Sacco, A; Stagno, F; Serafini, M; Mottadelli, F; Cazzaniga, G; Pagni, F; Chiarle, R; Azzoni, E; Sessa, A; Gambacorti Passerini, C; Elli, E; Mologni, L; Piazza, R
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients
2023 Fontana, D; Crespiatico, I; Crippa, V; Malighetti, F; Villa, M; Angaroni, F; De Sano, L; Aroldi, A; Antoniotti, M; Caravagna, G; Piazza, R; Graudenzi, A; Mologni, L; Ramazzotti, D
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC)
2023 Cordani, N; Lisini, D; Coccè, V; Paglia, G; Meanti, R; Cerrito, M; Tettamanti, P; Bonaffini, L; Paino, F; Alessandri, G; Marcianti, A; Giannì, A; Villa, C; Mauri, M; Mologni, L; Torsello, A; Pessina, A; Cazzaniga, M
Balanced SET levels favor the correct enhancer repertoire during cell fate acquisition
2023 Zaghi, M; Banfi, F; Massimino, L; Volpin, M; Bellini, E; Brusco, S; Merelli, I; Barone, C; Bruni, M; Bossini, L; Lamparelli, L; Pintado, L; D'Aliberti, D; Spinelli, S; Mologni, L; Colasante, G; Ungaro, F; Cioni, J; Azzoni, E; Piazza, R; Montini, E; Broccoli, V; Sessa, A
Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo
2023 Massimino, L; Palmieri, O; Facoetti, A; Fuggetta, D; Spanò, S; Lamparelli, L; D'Alessio, S; Cagliani, S; Furfaro, F; D'Amico, F; Zilli, A; Fiorino, G; Parigi, T; Noviello, D; Latiano, A; Bossa, F; Latiano, T; Pirola, A; Mologni, L; Piazza, R; Abbati, D; Perri, F; Bonini, C; Peyrin-Biroulet, L; Malesci, A; Jairath, V; Danese, S; Ungaro, F
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia
2023 Aroldi, A; Mauri, M; Ramazzotti, D; Villa, M; Malighetti, F; Crippa, V; Cocito, F; Borella, C; Bossi, E; Steidl, C; Scollo, C; Voena, C; Chiarle, R; Mologni, L; Piazza, R; Gambacorti Passerini, C
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients
2023 Malighetti, F; Arosio, G; Manfroni, C; Mauri, M; Villa, M; Manghisi, B; Inzoli, E; Rindone, G; Zambrotta, G; Civettini, I; Guglielmana, V; Ramazzotti, D; Giudici, G; Bombelli, S; Perego, R; Piazza, R; Mologni, L; Gambacorti-Passerini, C
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells
2023 Cordani, N; Mologni, L; Piazza, R; Tettamanti, P; Cogliati, V; Mauri, M; Villa, M; Malighetti, F; DI BELLA, C; Jaconi, M; Cerrito, M; Cavaletti, G; Lavitrano, M; Cazzaniga, M
Characterization of cancer subtypes associated with clinical outcomes by multi-omics integrative clustering
2023 Crippa, V; Malighetti, F; Villa, M; Graudenzi, A; Piazza, R; Mologni, L; Ramazzotti, D
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells
2023 Cordani, N; Mologni, L; Piazza, R; Cogliati, V; Pepe, F; Capici, S; DI BELLA, C; Jaconi, M; Cerrito, M; Villa, M; Tettamanti, P; Cavaletti, G; Lavitrano, M; Cazzaniga, M
Structure-activity exploration of a small-molecule allosteric inhibitor of T790M/L858R double mutant EGFR
2023 Foschi, F; Tinivella, A; Crippa, V; Pinzi, L; Mologni, L; Passarella, D; Rastelli, G
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma
2023 Mastini, C; Campisi, M; Patrucco, E; Mura, G; Ferreira, A; Costa, C; Ambrogio, C; Germena, G; Martinengo, C; Peola, S; Mota, I; Vissio, E; Molinaro, L; Arigoni, M; Olivero, M; Calogero, R; Prokoph, N; Tabbò, F; Shoji, B; Brugieres, L; Geoerger, B; Turner, S; Cuesta-Mateos, C; D’Aliberti, D; Mologni, L; Piazza, R; Gambacorti Passerini, C; Inghirami, G; Chiono, V; Kamm, R; Hirsch, E; Koch, R; Weinstock, D; Aster, J; Voena, C; Chiarle, R
Characterization of the transcriptional landscape of atypical Chronic Myeloid Leukemia at single-cell resolution
2022 Fontana, D; Crippa, V; Bassi, G; D'Aliberti, D; Mauri, M; Spinelli, S; Mastini, C; Bombelli, S; Civettini, I; Guglielmana, V; Perego, R; Ramazzotti, D; Mologni, L; Piazza, R; Gambacorti Passerini, C
Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy
2022 Villa, M; Malighetti, F; Sharma, G; Arosio, G; Sala, E; Manfroni, C; Fontana, D; Cordani, N; Meneveri, R; Zambon, A; Piazza, R; Pagni, F; Cortinovis, D; Mologni, L
Identification of non-ATP-competitive α-carboline inhibitors of the anaplastic lymphoma kinase
2022 Mologni, L; Orsato, A; Zambon, A; Tardy, S; Bisson, W; Schneider, C; Ceccon, M; Viltadi, M; D'Attoma, J; Pannilunghi, S; Vece, V; Gueyrard, D; Bertho, J; Scapozza, L; Goekjian, P; Gambacorti-Passerini, C
Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase
2022 Mologni, L; Tardy, S; Zambon, A; Orsato, A; Bisson, W; Ceccon, M; Viltadi, M; D'Attoma, J; Pannilunghi, S; Vece, V; Bertho, J; Goekjian, P; Scapozza, L; Gambacorti-Passerini, C
Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience
2022 Steidl, C; Aroldi, A; Mologni, L; Crespiatico, I; Fontana, D; Mastini, C; Fumagalli, M; Perfetti, P; Borin, L; Valentini, C; Piazza, R; Gambacorti-Passerini, C
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma
2022 Karaca Atabay, E; Mecca, C; Wang, Q; Ambrogio, C; Mota, I; Prokoph, N; Mura, G; Martinengo, C; Patrucco, E; Leonardi, G; Hossa, J; Pich, A; Mologni, L; Gambacorti Passerini, C; Brugieres, L; Geoerger, B; Turner, S; Voena, C; Cheong, T; Chiarle, R
Synergistic drug combinations preventdrug resistance in anaplastic large cell lymphomapreclinical models
2021 Sharma, G; Arosio, G; Villa, M; Mauri, M; Zappa, M; Magistroni, V; Ceccon, M; Redaelli, S; Crespiatico, I; Fontana, D; Mastini, C; Garbin, A; Lovisa, F; Mussolin, L; Piazza, R; Gambacorti Passerini, C; Mologni, L
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile